Works matching IS 00207136 AND DT 2023 AND VI 153 AND IP 4
Results: 20
Saliva biopsy: Detecting the difference of EBV DNA methylation in the diagnosis of nasopharyngeal carcinoma.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 882, doi. 10.1002/ijc.34561
- By:
- Publication type:
- Article
Bladder cancer risk in relation to occupations held in a nationwide case‐control study in Iran.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 765, doi. 10.1002/ijc.34560
- By:
- Publication type:
- Article
Long‐term prognostic impact of cardiovascular comorbidities in patients with prostate cancer receiving androgen deprivation therapy: A population‐based competing risk analysis.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 756, doi. 10.1002/ijc.34557
- By:
- Publication type:
- Article
Temporal patterns of childhood cancer survival 1991 to 2016: A nationwide register‐study based on data from the German Childhood Cancer Registry.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 742, doi. 10.1002/ijc.34556
- By:
- Publication type:
- Article
Regulatory B cells producing IL‐10 are increased in human tumor draining lymph nodes.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 854, doi. 10.1002/ijc.34555
- By:
- Publication type:
- Article
Association of kidney function with cancer incidence and its influence on cancer risk of smoking: The Japan Multi‐Institutional Collaborative Cohort Study.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 732, doi. 10.1002/ijc.34554
- By:
- Publication type:
- Article
Home‐based self‐sampling vs clinician sampling for anal precancer screening: The Prevent Anal Cancer Self‐Swab Study.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 843, doi. 10.1002/ijc.34553
- By:
- Publication type:
- Article
Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway—A population‐based matched cohort study.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 723, doi. 10.1002/ijc.34552
- By:
- Publication type:
- Article
Prognostic impact of kallikrein‐related peptidase transcript levels in prostate cancer.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 867, doi. 10.1002/ijc.34551
- By:
- Publication type:
- Article
Systemic inflammation influences the prognosis of patients with radically resected non‐small cell lung cancer and correlates with the immunosuppressive microenvironment.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 826, doi. 10.1002/ijc.34547
- By:
- Publication type:
- Article
Pan‐cancer efficacy and safety of anlotinib plus PD‐1 inhibitor in refractory solid tumor: A single‐arm, open‐label, phase II trial.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 815, doi. 10.1002/ijc.34546
- By:
- Publication type:
- Article
Comment on "The European response to the WHO call to eliminate cervical cancer as a public health problem".
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 893, doi. 10.1002/ijc.34540
- By:
- Publication type:
- Article
Clinical validation of methylation biomarkers for optimal detection of high‐grade vulvar intraepithelial neoplasia.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 783, doi. 10.1002/ijc.34537
- By:
- Publication type:
- Article
Olaparib efficacy in patients with germline BRCA‐mutated, HER2‐negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trial.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 803, doi. 10.1002/ijc.34525
- By:
- Publication type:
- Article
Proxalutamide in metastatic castration‐resistant prostate cancer: Primary analysis of a multicenter, randomized, open‐label, phase 2 trial.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 792, doi. 10.1002/ijc.34512
- By:
- Publication type:
- Article
Serum perfluorooctane sulfonate and perfluorooctanoate and risk of postmenopausal breast cancer according to hormone receptor status: An analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 775, doi. 10.1002/ijc.34487
- By:
- Publication type:
- Article
How to overcome resistance to immune checkpoint inhibitors in colorectal cancer: From mechanisms to translation.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 709, doi. 10.1002/ijc.34464
- By:
- Publication type:
- Article
Cancer stem cell‐immune cell collusion in immunotherapy.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 694, doi. 10.1002/ijc.34421
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 687, doi. 10.1002/ijc.34094
- Publication type:
- Article
Issue Information.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 895, doi. 10.1002/ijc.34093
- Publication type:
- Article